首页|基于附属敏感性设计碳青霉烯耐药肺炎克雷伯菌治疗方案的实践报道

基于附属敏感性设计碳青霉烯耐药肺炎克雷伯菌治疗方案的实践报道

扫码查看
目的:探讨基于附属敏感性(CS)设计的抗菌药物组合方案对碳青霉烯耐药肺炎克雷伯菌(CRKP)的临床效果和耐药性进展的影响,以期为临床耐药菌的治疗提供参考.方法:案例1 CRKP尿路感染药敏试验结果提示阿米卡星耐药时,考虑阿米卡星和β-内酰胺类药物之间存在CS,调整为双β-内酰胺类联合方案,即美洛西林联合阿莫西林钠/克拉维酸钾,评价该组合的治疗效果.案例 2 根据CRKP耐药性的演变,基于氨基糖苷类药物和四环素类药物、氨基糖苷类药物和β-内酰胺类药物的CS设计序贯给药的治疗方式,以及选择协同作用的药物组合同时给药,如哌拉西林钠他唑巴坦钠联合多西环素、美罗培南联合阿米卡星、美洛西林联合阿莫西林钠/克拉维酸钾,分析上述方案的治疗效果和耐药性的变化.结果:针对案例1的CRKP尿路感染,美洛西林联合阿莫西林钠/克拉维酸钾临床治疗有效,其协同作用可能来源于存在CS效应.案例 2 CS产生的药物治疗效果和耐药性的抑制受药物类型、序贯给药和同时给药等因素的影响.其中,采用具有协同作用的抗菌药物组合,当 2 种抗菌药物间具有CS效应时,药物治疗效果更佳;从耐药性来看,氨基糖苷类药物向β-内酰胺类药物转换可减少耐药性的进展.结论:在用药方案的设计中,运用抗菌药物间的CS效应或许可以成为提高药物治疗效果和抑制耐药性的策略之一.
Practice Repor t on Designing Treatment Regimens for Carbapenem-Resistant Klebsiella pneumoniae Based on Collateral Sensitivity
Objective:To explore the influence of antibiotic combination regimen based on collateral sensitivity(CS)on the clinical outcomes and drug resistance progression of carbapenem-resistant Klebsiella pneumoniae(CRKP),thereby providing insights for the treatment of clinical drug-resistant bacteria.Methods:Case 1:Results from drug sensitivity tests for CRKP urinary tract infections indicated resistance to amikacin.Considering the presence of CS between amikacin and β-lactams antibiotics,we adjusted the treatment to a combination regimen involving two β-lactams,mecillinam combined with amoxicillin sodium and clavulanate potassium,and subsequently evaluated the therapeutic effects of this combination.Case 2:According to the development of drug resistance of CRKP and CS observed among aminoglycosides,tetracyclines,and β-lactams,we designed a sequential administration mode and selected synergistic drug combinations for simultaneous administration,such as piperacillin sodium and tazobactam sodium combined with doxycycline,meropenem combined with amikacin,as well as mecillinam combined with amoxicillin sodium and clavulanate potassium.The therapeutic effects and changes in drug resistance associated with these regimens were analyzed.Results:In Case 1,mecillinam combined with amoxicillin sodium and clavulanate potassium was found to be effective in the treatment of CRKP urinary tract infections,with its synergistic effect likely arising from the presence of the CS effect.The therapeutic effects of CS in Case 2 and the inhibition of drug resistance are influenced by drug types and the methods of sequential and simultaneous administration.Notably,when a CS effect exists between the two antibacterial drugs,the therapeutic effects of drugs are enhanced.From the perspective of drug resistance,transitioning from aminoglycosides to β-lactams can mitigate the development of drug resistance.Conclusion:The design of drug regimens that utilizing the CS effects of antibiotics may represent a viable strategy to enhance the therapeutic effects and inhibit drug resistance.

carbapenem-resistant Klebsiella pneumoniaecollateral sensitivitytherapeutic regimenclinical effecacydrug-resistance

王群、伍婷、胡文

展开 >

宜春市人民医院药学部,宜春 336000

碳青霉烯耐药肺炎克雷伯菌 附属敏感性 用药方案 临床疗效 耐药性

2024

中国合理用药探索
中国执业药师协会

中国合理用药探索

影响因子:0.62
ISSN:2096-3327
年,卷(期):2024.21(12)